Project Grant G20RR031063

The National Institutes of Health Office of the Director awarded Coriell Institute for Medical Research $9.939 million on September 19, 2025, under the Construction Support program (CFDA 93.352) to build a cell engineering center supporting national biobanking infrastructure. The award funds construction of a greater-than-7,495 square foot Cell Engineering Center on the first floor of Coriell's new headquarters building in Camden, New Jersey. The center will serve as a core laboratory offering...

The National Institutes of Health Office of the Director awarded Wayne State University $16 million on September 15, 2025, under the Construction Support program (CFDA 93.352) to establish and operate the Wayne State University Advanced Technology Center in Detroit, Michigan. The award funds establishment of a 10,425-square-foot Advanced Technology Center in the new Health Sciences Building on the Wayne State University School of Medicine campus, consolidating three currently dispersed core...

The National Institutes of Health Office of the Director awarded $350,000 to Seattle Children's Hospital (doing business as Seattle Children's Research Institute) on September 1, 2026, under the Research Infrastructure Programs (CFDA 93.351) to purchase a digital ventilated cage system from Tecniplast for the Behavioral Phenotyping Core vivarium. The DVC system incorporates continuous, real-time monitoring of animal activity and environmental cage parameters including temperature, humidity,...

The National Institute of General Medical Sciences awarded The Nemours Foundation $1.14 million on August 15, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support the Delaware Comprehensive Sickle Cell Research Center (DE SCD COBRE) in Phase 3 funding. The award funds continued operation of a biomedical research center focused on sickle cell disease care and research development. The center recruits and develops sickle cell researchers across multiple...

The National Institutes of Health Office of the Director awarded Hartford Hospital $7,999,914 on September 15, 2025, under the Construction Support program (CFDA 93.352) to renovate a disused building and establish a modern, multi-modal clinical neuroscience research facility at the Institute of Living in Hartford, Connecticut. The facility will centralize the Institute of Living's ongoing and new research programs focused on psychiatric biotyping—the identification and classification of...

The National Institutes of Health Office of the Director awarded the Regents of the University of Michigan $348,594 on September 1, 2026, to acquire a Beckman Biomek I7 automated liquid-handling workstation equipped with a HEPA-filtered hood for the Center for Chemical Genomics high-throughput screening core facility. The Center for Chemical Genomics, located within the Life Sciences Institute at the University of Michigan, operates a high-throughput screening facility serving U-M faculty and...

The National Institute of Child Health and Human Development awarded Seattle Children's Hospital $380,774 on June 1, 2026, to develop and pilot a parent-facing tool designed to improve neonatal clinical trial recruitment and readiness among NICU parents. The project develops a web-based, mobile-accessible tool using multimedia and interactive features to prepare parents in neonatal intensive care units for discussions with clinical researchers about research enrollment. Development follows...

The National Institute of General Medical Sciences awarded Arkansas Children's Research Institute $1,167,290 on August 1, 2026, to establish and operate the Center for Childhood Obesity Prevention at the Arkansas Children's Research Institute under the Biomedical Research and Research Training program (CFDA 93.859). The center addresses pediatric obesity and cardiometabolic disorders in Arkansas and nationally by integrating biomedical discovery, clinical translation, and community engagement....

The National Institutes of Health Office of the Director awarded the Children's Hospital of Philadelphia $1.175 million on May 18, 2026, under the Research Infrastructure Programs (CFDA 93.351) to acquire a Bruker TIMSTOF Ultra 2 mass spectrometer for the institution's Proteomics Core Facility. The instrument will replace an aging Thermo QE HF system and expand the core's capacity to support high-resolution, quantitative proteomic profiling of clinically relevant and low-input samples across...

The National Institute of Child Health and Human Development awarded Cincinnati Children's Hospital Medical Center $445,500 on September 1, 2026, under the Child Health and Human Development Extramural Research Projects program (CFDA 93.HDR) to develop and optimize a compact CRISPR activation system using the miniature Cas12f nuclease within an adeno-associated virus (AAV) vector for modulating lung vascular enhancers. The project targets regulatory DNA elements that control cell- and...